Heron Therapeutics (HRTX) Gross Margin (2017 - 2026)
Heron Therapeutics' Gross Margin was 69.28% in Q2 2026, down 4.23 percentage points from 73.50% a year earlier and down 0.08 percentage points from the prior quarter.
Powered by 
Analysis
Heron Therapeutics (HRTX) Gross Margin (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Heron Therapeutics' Gross Margin was 70.07% through Jun 30, 2026, down 4.54 percentage points year-over-year; for FY2025, it was 73.31%, up 0.09 percentage points from FY2024.
- Gross Margin shows a five-year change of +60.66 percentage points (FY2020 to FY2025).
- In earlier years, Gross Margin was 73.21% in FY2024 (+24.46 pp), 48.75% in FY2023 (-0.28 pp), 49.04% in FY2022 (+2.33 pp) and 46.70% in FY2021 (+34.05 pp).
- Quarterly Gross Margin has moved between 36.53% (Q2 2023) and 78.26% (Q1 2025) over five years.
- Compared with a year earlier, Gross Margin has declined for four straight quarters, with an average year-over-year change of +2.55 percentage points over the last eight quarters.
- The best year-over-year quarter for Gross Margin over five years was Q2 2024 (a gain of 34.27 percentage points); the worst was Q3 2021 (a drop of 12.84 percentage points).
- Per Business Quant data, HRTX's Gross Margin in the three quarters before Q2 2026 was 69.35% (Q1 2026), 72.61% (Q4 2025) and 68.82% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 85.33% |
| 10 | Heron Therapeutics | 58.85 Mn | -130.71 Mn | 26.09 Mn | 69.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.28% |
| Mar 31, 2026 | 69.35% |
| Dec 31, 2025 | 72.61% |
| Sep 30, 2025 | 68.82% |
| Jun 30, 2025 | 73.50% |
| Mar 31, 2025 | 78.26% |
| Dec 31, 2024 | 74.92% |
| Sep 30, 2024 | 71.17% |
| Jun 30, 2024 | 70.80% |
| Mar 31, 2024 | 75.64% |
| Dec 31, 2023 | 71.12% |
| Sep 30, 2023 | 42.08% |
| Jun 30, 2023 | 36.53% |
| Mar 31, 2023 | 43.09% |
| Dec 31, 2022 | 57.95% |
| Sep 30, 2022 | 44.58% |
| Jun 30, 2022 | 41.46% |
| Mar 31, 2022 | 51.59% |
| Dec 31, 2021 | 47.03% |
| Sep 30, 2021 | 51.14% |
API Access
Heron Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=HRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "HRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=HRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();